Hologic, Inc. (BIT:1HOLX)

Hologic Statistics

Total Valuation

Hologic has a market cap or net worth of EUR 14.41 billion. The enterprise value is 14.78 billion.

Market Cap	14.41B
Enterprise Value	14.78B

Important Dates

The last earnings date was Monday, November 3, 2025.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	222.91M
Shares Outstanding	n/a
Shares Change (YoY)	-4.20%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	1.57%
Owned by Institutions (%)	98.97%
Float	219.22M

Valuation Ratios

The trailing PE ratio is 29.79 and the forward PE ratio is 16.25.

PE Ratio	29.79
Forward PE	16.25
PS Ratio	4.11
PB Ratio	3.34
P/TBV Ratio	20.60
P/FCF Ratio	18.32
P/OCF Ratio	15.94
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.36, with an EV/FCF ratio of 18.78.

EV / Earnings	30.55
EV / Sales	4.14
EV / EBITDA	12.36
EV / EBIT	16.15
EV / FCF	18.78

Financial Position

The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.52.

Current Ratio	3.75
Quick Ratio	2.87
Debt / Equity	0.52
Debt / EBITDA	1.90
Debt / FCF	2.85
Interest Coverage	9.06

Financial Efficiency

Return on equity (ROE) is 11.12% and return on invested capital (ROIC) is 8.58%.

Return on Equity (ROE)	11.12%
Return on Assets (ROA)	7.30%
Return on Invested Capital (ROIC)	8.58%
Return on Capital Employed (ROCE)	13.20%
Revenue Per Employee	496,004
Profits Per Employee	68,428
Employee Count	7,070
Asset Turnover	0.45
Inventory Turnover	2.36

Taxes

In the past 12 months, Hologic has paid 98.78 million in taxes.

Income Tax	98.78M
Effective Tax Rate	16.96%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	60.59
200-Day Moving Average	n/a
Relative Strength Index (RSI)	61.32
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.12

Income Statement

In the last 12 months, Hologic had revenue of EUR 3.51 billion and earned 483.79 million in profits. Earnings per share was 2.13.

Revenue	3.51B
Gross Profit	2.13B
Operating Income	907.45M
Pretax Income	582.56M
Net Income	483.79M
EBITDA	1.16B
EBIT	907.45M
Earnings Per Share (EPS)	2.13

Balance Sheet

The company has 1.89 billion in cash and 2.25 billion in debt, giving a net cash position of -359.95 million.

Cash & Cash Equivalents	1.89B
Total Debt	2.25B
Net Cash	-359.95M
Net Cash Per Share	n/a
Equity (Book Value)	4.32B
Book Value Per Share	19.40
Working Capital	2.30B

Cash Flow

In the last 12 months, operating cash flow was 904.03 million and capital expenditures -117.16 million, giving a free cash flow of 786.87 million.

Operating Cash Flow	904.03M
Capital Expenditures	-117.16M
Free Cash Flow	786.87M
FCF Per Share	n/a

Margins

Gross margin is 60.82%, with operating and profit margins of 25.88% and 13.80%.

Gross Margin	60.82%
Operating Margin	25.88%
Pretax Margin	16.61%
Profit Margin	13.80%
EBITDA Margin	32.95%
EBIT Margin	25.88%
FCF Margin	22.44%

Dividends & Yields

Hologic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.20%
Shareholder Yield	4.20%
Earnings Yield	3.36%
FCF Yield	5.46%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hologic has an Altman Z-Score of 4.05 and a Piotroski F-Score of 7.

Altman Z-Score	4.05
Piotroski F-Score	7